Multi-center Collaborative to Enhance Quality and Outcomes in the Management of Cardiogenic Shock

Status: Recruiting
Location: See all (3) locations...
Study Type: Observational
SUMMARY

This large real-world international prospective registry will provide a unique opportunity to comprehensively understand the contemporary management, clinical course and short as well as long-term outcomes of all Cardiogenic Shock (CS) patients cared for at four high volume dedicated shock care centers. As the first true North American multicenter CS collaborative with a uniform dedicated and comprehensive case report form, the high patient volumes and wide spectrum of clinical acuity seen at these institutions will provide valuable insight into the factors associated with adverse outcomes; and will serve as a blueprint for future clinical trial designs that may better inform clinical practice.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Primary diagnosis of cardiogenic shock at time of index evaluation; including acute myocardial infarction- and acute decompensated heart failure-cardiogenic shock phenotypes

• Patients with cardiac arrest complicating cardiogenic shock and those with massive pulmonary embolism with right ventricular cardiogenic shock will also be eligible for the registry

Locations
United States
Florida
Cleveland Clinic Florida
RECRUITING
Weston
Virginia
Inova Heart and Vascular Institute
RECRUITING
Falls Church
Other Locations
Canada
University of Toronto
RECRUITING
Toronto
Contact Information
Primary
John Kirk
john.kirk@hsc.utah.edu
801-585-2944
Time Frame
Start Date: 2022-05-25
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 500
Treatments
Cardiogenic shock cohort
Primary diagnosis of Cardiogenic Shock at the time of index evaluation. The clinical and hemodynamic criteria used to diagnose Cardiogenic Shock will be those as defined in the Society for Cardiovascular Angiography and Interventions clinical expert consensus statement on the classification of cardiogenic shock.
Related Therapeutic Areas
Sponsors
Leads: STAVROS G DRAKOS

This content was sourced from clinicaltrials.gov